Offer - Urjas Oil for just ₹ 1 X
Eldcef 250 Mg Injection is a prescription drug, available for use as Injection. Primarily, it is used for the treatment of Meningitis. Eldcef 250 Mg Injection also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Eldcef 250 Mg Injection. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Eldcef 250 Mg Injection as well, which are listed below. Usually, these side effects of Eldcef 250 Mg Injection go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Eldcef 250 Mg Injection's effect during pregnancy is Safe and Safe while nursing. It is important to know if Eldcef 250 Mg Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Eldcef 250 Mg Injection related warnings section.
Eldcef 250 Mg Injection is contraindicated in people with pre-existing medical conditions like Kidney Disease as it can result in adverse effects. Other conditions have been mentioned below in the Eldcef 250 Mg Injection contraindications section.
Drug interactions for Eldcef 250 Mg Injection have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Eldcef 250 Mg Injection, it is important to know that it is not safe while driving, and is not habit-forming.
Eldcef 250 Mg Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Eldcef 250 Mg Injection safe for pregnant women?
Eldcef is safe to take during pregnancy.
Is the use of Eldcef 250 Mg Injection safe during breastfeeding?
Eldcef does not show any harmful effects in lactating women.
What is the effect of Eldcef 250 Mg Injection on the Kidneys?
Very few cases of side effects of Eldcef on kidney have been reported.
What is the effect of Eldcef 250 Mg Injection on the Liver?
Eldcef is not harmful for the liver.
What is the effect of Eldcef 250 Mg Injection on the Heart?
Using Eldcef does not have any harmful effects on the heart.
If you are suffering from any of the following diseases, you should not take Eldcef 250 Mg Injection unless your doctor advises you to do so -
Is this Eldcef 250 Mg Injection habit forming or addictive?
No, there is no any evidence that Eldcef 250 Mg Injection is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Eldcef 250 Mg Injection as you may feel sleepy.
Is it safe?
Yes, Eldcef 250 Mg Injection is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Eldcef 250 Mg Injection in mental disorders is not effective.
Interaction between Food and Eldcef 250 Mg Injection
Taking Eldcef 250 Mg Injection with food does not cause any problems.
Interaction between Alcohol and Eldcef 250 Mg Injection
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Eldcef 250 Mg Injection.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cedax® (ceftibuten capsules)
KD Tripathi. Essentials of Medical Pharmacology. Eighth Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2019